Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 5/2008

01-09-2008 | Original Paper

Demographic Characteristics and Sexual Behaviors Associated with Methamphetamine Use among MSM and Non-MSM diagnosed with AIDS in Los Angeles County

Authors: Amy Rock Wohl, Douglas M. Frye, Denise F. Johnson

Published in: AIDS and Behavior | Issue 5/2008

Login to get access

Abstract

Demographic and behavioral factors associated with methamphetamine use are presented for 455 men who have sex with men (MSM) and 228 non-MSM diagnosed with AIDS in Los Angeles County (LAC) from 2000 to 2004, as there are limited population-based data for these subgroups. Lifetime methamphetamine use was 35% for MSM, 14% for non-MSM, 50% for white MSM, and 35% for black MSM. Methamphetamine use in the previous 12 months among MSM (11%) and non-MSM (0.4%) was less than lifetime use. Compared to MSM with no history of methamphetamine use in a multivariate analysis, MSM methamphetamine users were more likely to be non-Latino (white or black) (OR = 2.8, 95% CI: 1.6, 4.9) compared to Latino and reported ≥10 sexual partners in the previous 12 months (OR = 3.1, 95% CI: 1.7, 5.6). These data indicate that methamphetamine has been widely used by both MSM and non-MSM with AIDS in LAC and that lifetime use is associated with sexual risk behaviors among MSM.
Literature
Boddiger, D. (2005). Methamphetamine use linked to rising HIV transmission. Lancet, 365, 1217–1218.PubMedCrossRef
Bolding, G., Hart, G., Sherr, L., & Elford, J. (2006). Use of crystal methamphetamine among gay men in London. Addiction 101, 1622–1630.PubMedCrossRef
Colfax, G., Coates, T. J., Husnik, M. J., Huang, Y., Buchbinder, S., Koblin, B., Chesney, M., & Vittinghoff, E. (2005). Longitudinal patterns of methamphetamine, popper (amyl nitrate) and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health, 82, i62–i70.PubMed
Collins, R. L., Kanouse, D. E., Gifford, A. L., Senterfitt, J. W., Schuster, M. A., McCaffrey, D. F., Shapiro, M. F., & Wenger, N. S. (2001). Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychology, 20, 351–360.PubMedCrossRef
Diaz, R. M., Heckert, A. L., & Sanchez, J. (2005). Reasons for stimulant use among Latino gay men in San Francisco: A comparison between methamphetamine and cocaine users. Journal of Urban Health, 82, i71–i78.PubMed
Fernandez, M. I., Bowen, G. S., Warren, J. C., Ibanez, G. E., Hernandez, N., Harper, G. W., & Prado, G. (2007). Crystal methamphetamine: A source of added sexual risk for Hispanic men who have sex with men?. Drug and Alcohol Dependence, 86, 245–252.PubMedCrossRef
Frosch, D., Shoptaw, S., Huber, A., Rawson, R. A., & Ling, W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment, 13, 483–486.PubMedCrossRef
Halkitis, P. N., Parsons, J. T., & Stirratt, M. J. (2001). A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality, 41, 17–35.PubMedCrossRef
Halkitis, P. N., Shrem, M. T., & Martin, F. W. (2005a). Sexual behavior patterns of methamphetamine-using gay and bisexual men. Substance Use and Misuse, 40, 703–719.PubMedCrossRef
Halkitis, P. N., Green, K. A., & Mourgues, P. (2005b). Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: Findings from project BUMPS. Journal of Urban Health, 82, i18–i125.PubMed
Kall, K. I. (1992). Effects of amphetamine on sexual behavior of male IV drug users in Stockholm—A pilot study. AIDS Education and Prevention, 4, 6–17.PubMed
Kurtz, S. P. (2005). Post-circuit blues: Motivations and consequences of crystal Meth use among gay men in Miami. AIDS and Behavior, 9, 63–72.PubMedCrossRef
Langford, D., Adame, A., Grigorian, A., Grant, I., McCutchan, J. A., Ellis, R. J., Marcotte, T. D., & Masliah, E. (2003). Patterns of selective neuronal damage in Methamphetamine user AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 34, 467–474.PubMedCrossRef
Mansergh, G., Colfax, G. N., Marks, G., Rader, M., Guzman, R., & Buchbinder, S. (2001). The circuit party men’s health survey: Findings and implications for gay and bisexual men. American Journal of Public Health, 91, 953–958.PubMedCrossRef
Molitor, F., Truax, S. R., Ruiz, J. D., & Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. Western Journal of Medicine, 168, 93–97.PubMed
Molitor, F., Ruiz, J. D., Flynn, J., Mikanda, J. H., Sun, R. K., Anderson, R. (1999). Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. American Journal of Drug and Alcohol Abuse, 3, 475–493.CrossRef
Newmeyer, J. A. (2003). Patterns and trends of drug use in the San Francisco Bay area. Journal of Psychoactive Drugs, 35, 127–132.PubMed
Reback, C. J., Larkins, S., & Shoptaw, S. (2004). Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after treatment. AIDS and Behavior, 8, 87–98.PubMedCrossRef
Semple, S. J., Patterson, T. L., & Grant, I. (2004). A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug and Alcohol Dependency, 76, 203–212.CrossRef
Shoptaw, S., Reback, C. J., & Freese, T. E. (2002). Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. Journal of Addictive Diseases, 21, 91–105.PubMedCrossRef
Shoptaw, S., Reback, C. J., Peck, J. A., Yang, X., Rotheram-Fuller, E., Larkins, S., Veniegas, R. C., Freese, T. E., & Hucks-Ortiz, C. (2005) Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence, 78, 125–134.PubMedCrossRef
Shoptaw S. (2006) Methamphetamine use in urban gay and bisexual populations. Topics in HIV Medicine, 14, 84–87.PubMed
Sullivan, P. S., Nakashima, A. K., Purcell, D. W., David, W., & Ward, J. W. (1998). Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: Western United States versus other regions. Journal of Acquired Immune Deficiency Syndromes, 19, 266–273.
Urbina, A., Jones, K. (2004). Crystal methamphetamine, its analogies, and HIV infection: medical and psychiatric aspects of a new epidemic. Clinical Infectious Diseases, 38, 890–894.PubMedCrossRef
Wohl, A. R., Johnson, D. F., Lu, S., Frye, D., Bunch, G., & Simon, P. A. (2004). Recent increase in high-risk sexual behaviors among sexually-active MSM living with AIDS in Los Angeles County. Journal of Acquired Immune Deficiency Syndromes, 35, 209–211.PubMedCrossRef
Wohl A. R., Johnson D. F., Frye D. M. (2007). Increases in non-injection methamphetamine use in men who have sex with men, men who do not have sex with men and Latino men diagnosed with AIDS in Los Angeles County, 2000 through 2004. Journal of Acquired Immune Deficiency Syndromes 45, 601–603.PubMedCrossRef
Metadata
Title
Demographic Characteristics and Sexual Behaviors Associated with Methamphetamine Use among MSM and Non-MSM diagnosed with AIDS in Los Angeles County
Authors
Amy Rock Wohl
Douglas M. Frye
Denise F. Johnson
Publication date
01-09-2008
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2008
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9315-7

Other articles of this Issue 5/2008

AIDS and Behavior 5/2008 Go to the issue

Original Paper

Universal Precautions in the Era of HIV/AIDS: Perception of Health Service Providers in Yunnan, China

Original Paper

A Daily Process Investigation of Alcohol-involved Sexual Risk Behavior Among Economically Disadvantaged Problem Drinkers Living with HIV/AIDS

Original Paper

Gender, Drug Use, and Perceived Social Support Among HIV Positive Patients

Original paper

Factors Associated with Sexual Risk Behavior Among Persons Living with HIV: Gender and Sexual Identity Group Differences

Original Paper

Development of Parallel Scales to Measure HIV-Related Stigma

Original Paper

Measuring HIV-related Stigma Among Chinese Service Providers: Confirmatory Factor Analysis of a Multidimensional Scale
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits